公开(公告)号：US20240398802A1

公开(公告)日：2024-12-05

申请号：US18732027

申请日：2024-06-03

Applicant: Noor Brands Company, LLC

Inventor： Adnan Mjalli ,  Wiley William Hitchcock

IPC: A61K31/506 ,  A61K9/00 ,  A61K31/4188 ,  A61K31/573 ,  A61K31/58 ,  A61K36/537 ,  A61K47/10 ,  A61K47/12 ,  A61K47/20 ,  A61K47/36 ,  A61P17/14

Abstract: Disclosed are compositions and methods for the prevention and/or treatment of hair loss. The provided compositions comprise a chitosan gel-based carrier for the transdermal delivery of active hair growth agents. The disclosed compositions allow for the use of multiple active agents, including minoxidil, finasteride, and clobetasol propionate, in combination in a topical formulation that exhibits effective delivery of such agents t for treatment of hair loss.

公开(公告)号：US12115220B2

公开(公告)日：2024-10-15

申请号：US17309186

申请日：2019-11-05

Applicant: Inspired Material Solutions, LLC

Inventor： Mark A. Latta

IPC: A61K36/00 ,  A61K9/00 ,  A61K31/02 ,  A61K31/045 ,  A61K31/047 ,  A61K31/085 ,  A61K31/14 ,  A61K31/155 ,  A61K31/167 ,  A61K31/221 ,  A61K31/245 ,  A61K31/4164 ,  A61K31/4178 ,  A61K31/4425 ,  A61K31/7036 ,  A61K31/714 ,  A61K31/717 ,  A61K33/00 ,  A61K33/06 ,  A61K33/16 ,  A61K33/30 ,  A61K33/40 ,  A61K33/42 ,  A61K35/644 ,  A61K36/185 ,  A61K36/28 ,  A61K36/484 ,  A61K36/537 ,  A61K36/889 ,  A61K38/12 ,  A61K47/34

CPC classification number: A61K47/34 ,  A61K9/006 ,  A61K31/02 ,  A61K31/045 ,  A61K31/047 ,  A61K31/085 ,  A61K31/14 ,  A61K31/155 ,  A61K31/167 ,  A61K31/221 ,  A61K31/245 ,  A61K31/4164 ,  A61K31/4178 ,  A61K31/4425 ,  A61K31/7036 ,  A61K31/714 ,  A61K31/717 ,  A61K33/00 ,  A61K33/06 ,  A61K33/16 ,  A61K33/30 ,  A61K33/40 ,  A61K33/42 ,  A61K35/644 ,  A61K36/185 ,  A61K36/28 ,  A61K36/484 ,  A61K36/537 ,  A61K36/889 ,  A61K38/12

Abstract: An oral mucosal carrier comprising a combination of two different viscosity dimethicone components, wherein the difference between the two different viscosity dimethicone components is about 2.0 million cP or greater; and comprising at least one active agent.

公开(公告)号：US20240269221A1

公开(公告)日：2024-08-15

申请号：US18570097

申请日：2021-08-18

Applicant: Prashanth VARKEY ,  Rosemary PRASHANTH

Inventor： Prashanth VARKEY ,  Rosemary PRASHANTH

IPC: A61K36/906 ,  A61K9/48 ,  A61K31/352 ,  A61K31/4525 ,  A61K36/537 ,  A61K36/67

CPC classification number: A61K36/906 ,  A61K9/4825 ,  A61K31/352 ,  A61K31/4525 ,  A61K36/537 ,  A61K36/67

Abstract: A synergistic phytoextract formulation for anti-inflammatory action is disclosed. The synergistic phytoextract formulation comprises effective amount of phytoextracts selected from the group consisting of Elettaria cardamomum (cardamomum) in the range of 40% by weight, Salvia rosmarinus (rosemary) in the range of 40% by weight and piperine extract in the range 2% by weight. The active molecule 1, 8 Cineol from the Elettaria cardamomum (cardamomum) and Salvia rosmarinus (rosemary) exhibits excellent muscle relaxant effects by decreasing smooth muscle contractions of airways, anti-inflammatory action by blocking cytokines release and analgesic effects. The synergistic phytoextract formulation is formulated for oral administration in the forms of capsules, microcapsules or tablets.

公开(公告)号：US20240261357A1

公开(公告)日：2024-08-08

申请号：US18576171

申请日：2022-07-01

Applicant: Altergon S.A.

Inventor： Andrea Maria Giori ,  Andrea Alimonti

IPC: A61K36/537 ,  A61P9/00 ,  A61P9/04 ,  A61P9/06

CPC classification number: A61K36/537 ,  A61P9/00 ,  A61P9/04 ,  A61P9/06

Abstract: The present invention relates to the use of Salvia haenkei extract as an active agent in the treatment of heart diseases, being able to offer a significant contribution in slowing, relieving, reducing and/or preventing alterations and damages of the cardiac tissue. Furthermore, the present invention also relates to a pharmaceutical composition comprising Salvia haenkei extract and suitable pharmaceutically acceptable excipients, for use in the treatment of heart diseases.

公开(公告)号：US20240226220A9

公开(公告)日：2024-07-11

申请号：US18277043

申请日：2022-02-11

Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY ,  SOUTHWEST COLLEGE OF NATUROPATHIC MEDICINE

Inventor： Jeffrey Olaf Langland ,  Bertram Jacobs

IPC: A61K36/539 ,  A61K36/287 ,  A61K36/537 ,  A61K36/78 ,  A61K36/82 ,  A61K36/888 ,  A61P31/14

CPC classification number: A61K36/539 ,  A61K36/287 ,  A61K36/537 ,  A61K36/78 ,  A61K36/82 ,  A61K36/888 ,  A61P31/14 ,  A61K2236/333

Abstract: This invention is directed to oral botanical compositions comprising plant extracts, methods of preparing the same, and methods of using the same for treating an infection.

公开(公告)号：US20240226214A1

公开(公告)日：2024-07-11

申请号：US17995072

申请日：2021-03-29

Applicant: YALE UNIVERSITY

Inventor： YungChi Cheng ,  Wing Lam

IPC: A61K36/185 ,  A61K36/07 ,  A61K36/24 ,  A61K36/28 ,  A61K36/282 ,  A61K36/41 ,  A61K36/48 ,  A61K36/484 ,  A61K36/537 ,  A61K36/539 ,  A61K36/65 ,  A61K36/739 ,  A61K36/74 ,  A61K36/82 ,  A61K45/06 ,  A61P29/00

CPC classification number: A61K36/185 ,  A61K36/07 ,  A61K36/24 ,  A61K36/28 ,  A61K36/282 ,  A61K36/41 ,  A61K36/48 ,  A61K36/484 ,  A61K36/537 ,  A61K36/539 ,  A61K36/65 ,  A61K36/739 ,  A61K36/74 ,  A61K36/82 ,  A61K45/06 ,  A61P29/00

Abstract: The present invention relates to methods of using herbal extracts for treating and preventing inflammatory and fibrotic diseases and disorders. Additionally, the herbal extracts of the present invention are also useful for treating diseases and disorders that are caused by bacterial, viral, or fungal infections.

公开(公告)号：US20240075089A1

公开(公告)日：2024-03-07

申请号：US18260195

申请日：2020-12-30

Applicant: Arbor Life Holdings, Ltd.

Inventor： Peter R. Feldman ,  Luciano E. Marra ,  Dennis M. Brown ,  Deborah J. Cahan

IPC: A61K36/28 ,  A61K31/10 ,  A61K31/355 ,  A61K31/4188 ,  A61K31/522 ,  A61K36/03 ,  A61K36/074 ,  A61K36/21 ,  A61K36/232 ,  A61K36/31 ,  A61K36/42 ,  A61K36/48 ,  A61K36/537 ,  A61K36/539 ,  A61K36/704 ,  A61K36/73 ,  A61K45/06 ,  A61K47/46 ,  A61P17/00 ,  A61P17/14

CPC classification number: A61K36/28 ,  A61K31/10 ,  A61K31/355 ,  A61K31/4188 ,  A61K31/522 ,  A61K36/03 ,  A61K36/074 ,  A61K36/21 ,  A61K36/232 ,  A61K36/31 ,  A61K36/42 ,  A61K36/48 ,  A61K36/537 ,  A61K36/539 ,  A61K36/704 ,  A61K36/73 ,  A61K45/06 ,  A61K47/46 ,  A61P17/00 ,  A61P17/14

Abstract: The present disclosure provides botanicals and/or biotin or analogs thereof, that proliferate or reduce stem cell populations and activate or attenuate Wat/β-Catenin signaling and thus treat or prevent diseases related to signal transduction. In particular, the disclosure provides Botanicals and Biotin or analogs thereof, that proliferate or reduce stem cell populations and activate or attenuate Wnt/β-Catenin signaling in tissues expressing Wnt1OB including, adipose, adrenal, artery, blood, bone marrow, brain, breast, cervix, colon, esophagus, heart, intestine, kidney, liver, lung, muscle, ovary, pituitary, prostate, skin, spleen, testis, thyroid, uterus and vagina. The present compositions and methods are particularly suited to growing and melanizing hair.

公开(公告)号：US20230390352A1

公开(公告)日：2023-12-07

申请号：US18026261

申请日：2020-11-17

Applicant: UNDBIO.CO.,LTD

Inventor： Se-Chan KANG ,  Yang-Mi HER ,  Hee-Ju SUH ,  Jeong-Eun KWON

IPC: A61K36/537 ,  A61P25/24

CPC classification number: A61K36/537 ,  A61P25/24 ,  A61K2236/333

Abstract: The present invention relates to a composition comprising a Salvia miltiorrhiza extract for prevention and treatment of depression in menopausal women. The Salvia miltiorrhiza extract of the present invention is characterized by regulating the release of luteinizing hormone and follicle-stimulating hormone and increasing the release of serotonin and norepinephrine to prevent, alleviate, and treat the hormonal change and depression occurring after menopause. In addition, since the raw material is highly stable, the composition comprising a danshensu-containing Salvia miltiorrhiza extract as an active ingredient retains the efficacy during long-term storage and thus can be suitable for use as an industrial substance. Therefore, the composition comprising a Salvia miltiorrhiza extract as an active ingredient according to the present invention can control hormones in menopausal women and thus can be used as a pharmaceutical composition for prevention and treatment of depression in menopausal women or as a health functional food composition for prevention and alleviation of depression in menopausal women.

公开(公告)号：US20230158092A1

公开(公告)日：2023-05-25

申请号：US17990699

申请日：2022-11-20

Applicant: Ming Jie WU

Inventor： Ming Jie WU

IPC: A61K36/428 ,  A61K36/75 ,  A61K36/758 ,  A61K36/062 ,  A61K36/288 ,  A61K36/539 ,  A61K36/537 ,  A61K36/9066 ,  A61K36/90 ,  A61K36/79 ,  A61K36/233 ,  A61K36/074 ,  A61K36/258 ,  A61K35/586 ,  A23L33/105

CPC classification number: A61K36/428 ,  A61K36/75 ,  A61K36/758 ,  A61K36/062 ,  A61K36/288 ,  A61K36/539 ,  A61K36/537 ,  A61K36/9066 ,  A61K36/90 ,  A61K36/79 ,  A61K36/233 ,  A61K36/074 ,  A61K36/258 ,  A61K35/586 ,  A23L33/105

Abstract: The invention provides unique compositions containing mixtures of extracts from medicinal plants and animal parts, as well as related uses for improving health and treating diseases. The inventive compositions provide a wide range of health benefits in the human body in comparison to effects from individual components contained therein.

公开(公告)号：US11654131B1

公开(公告)日：2023-05-23

申请号：US17966901

申请日：2022-10-17

Applicant: Matthias W Rath

Inventor： Aleksandra Niedzwiecki ,  Matthias W Rath ,  Parthena Boulikas ,  Anna Goc ,  Gabriela Lopez

IPC: A61K31/375 ,  A61P35/00 ,  A61K31/355 ,  A61K31/197 ,  A61K31/675 ,  A61K31/519 ,  A61K33/18 ,  A61K33/04 ,  A61K31/14 ,  A61K31/047 ,  A61K31/685 ,  A61K31/353 ,  A61K36/48 ,  A61K36/537 ,  A61K36/53 ,  A23L33/15 ,  A23L33/16 ,  A23L33/125 ,  A23L33/105 ,  A61P5/24

CPC classification number: A61K31/375 ,  A23L33/105 ,  A23L33/125 ,  A23L33/15 ,  A23L33/16 ,  A61K31/047 ,  A61K31/14 ,  A61K31/197 ,  A61K31/353 ,  A61K31/355 ,  A61K31/519 ,  A61K31/675 ,  A61K31/685 ,  A61K33/04 ,  A61K33/18 ,  A61K36/48 ,  A61K36/53 ,  A61K36/537 ,  A61P5/24 ,  A61P35/00 ,  A23V2002/00

Abstract: A basic mix or Mix 1 or Mix 2 is highly effective in treating estrogen related complications in females. The estrogen related diseases such as cancer are also treated if they are Apo E based manifestations. The basic mix or Mix 1 or Mix 2 comprises of a combination of a Vitamin C (Ca ascorbate) 10 mg-100,000 mg, Vitamin E (D-alpha-tocopherol) 1-3,000 mg, Vitamin B5 1-20,000 mg, Vitamin B6 1-1,000 mg, Folic acid 1-3,000 mcg, Iodine (Kelp) 1-2,000 mcg, Selenium 1-2,000 mcg, Choline 1-5,000 mg, Inositol 1-5000 mg, Phosphatidyl serine 1-1,500 mg, Daidzein 1-1,500 mg, Glycitein 0.1-1,000 mg, Genistein 1-2,500 mg, Red clover 1-1,500 mg, Rosemary extract 1-6,000 mg and Chaste tree berry (Vitex agnus-castus) 1-2,000 mg. The treatment by administering Mix 1 decreases estrogen dependent breast cancer cells proliferation and decrease in expression of cancer promoting cellular markers in cancer cells (iNOS, ApoE).